Oncobox

Oncobox is a healthcare and medical devices startup headquartered in the United States. Their slogan "Tailor the right cancer drug to each patient" encapsulates their mission to transform cancer care through precision medicine. Leveraging artificial intelligence and systems biology, Oncobox integrates deep molecular profiling, encompassing DNA mutations and RNA gene expression analysis, with comprehensive data analytics. Their approach has demonstrated remarkable success in identifying effective treatment strategies, resulting in a twofold decrease in disease progression and a significant increase in progression-free survival (PFS) for late-stage cancer patients. Since its founding in 2015, Oncobox has gained recognition for its innovative use of deep molecular profiling, setting new standards in the precision and efficacy of cancer treatment. The effectiveness of their technology is supported by both prospective and retrospective studies, backing their claim for unmatched precision in treatment. Although specific details about their latest investment are not available at this time, Oncobox's pioneering work in precision medicine has positioned them as a notable player in the field of cancer care.